U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 06:17:54 GMT 2025
Edited
by admin
on Wed Apr 02 06:17:54 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
X126G5DZ36
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ongericimab [INN]
Preferred Name English
ONGERICIMAB
INN  
Official Name English
IMMUNOGLOBULIN G4, ANTI-(NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL JS002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS002 .KAPPA.-CHAIN, DIMER
Common Name English
JS 002
Code English
JS002
Common Name English
JS-002
Code English
Ongericimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
Code System Code Type Description
INN
11188
Created by admin on Wed Apr 02 06:17:54 GMT 2025 , Edited by admin on Wed Apr 02 06:17:54 GMT 2025
PRIMARY
SMS_ID
300000024170
Created by admin on Wed Apr 02 06:17:54 GMT 2025 , Edited by admin on Wed Apr 02 06:17:54 GMT 2025
PRIMARY
FDA UNII
X126G5DZ36
Created by admin on Wed Apr 02 06:17:54 GMT 2025 , Edited by admin on Wed Apr 02 06:17:54 GMT 2025
PRIMARY
CAS
2145096-91-7
Created by admin on Wed Apr 02 06:17:54 GMT 2025 , Edited by admin on Wed Apr 02 06:17:54 GMT 2025
PRIMARY
NCI_THESAURUS
C174940
Created by admin on Wed Apr 02 06:17:54 GMT 2025 , Edited by admin on Wed Apr 02 06:17:54 GMT 2025
PRIMARY
From To
1_22 1_95
2_22 2_95
2_125 4_213
2_138 2_194
2_252 2_312
1_125 3_213
2_358 2_416
3_23 3_88
3_133 3_193
4_23 4_88
4_133 4_193
1_138 1_194
1_217 2_217
1_220 2_220
1_252 1_312
1_358 1_416
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_288
N 2_288
Related Record Type Details
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_438] [2_438] C-TERMINUS LYSINE K3Z4F929H6
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL